Log in to search using one of your social media accounts:

 

How to minimize your risk of melanoma
It's Skin Cancer Awareness Month and today is "Melanoma Monday." One in five people will develop skin cancer by age 70. Melanoma is the most dangerous form of skin cancer. Dr. Elizabeth Hale, associate professor of dermatology at NYU Langone Medical Center, joins "CBS This Morning" to offer advice on how to minimize your risk factors. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 7, 2018 Category: Consumer Health News Source Type: news

T-Cell Biomarker Predicts Response to CAR T-Cell Therapy in CLL T-Cell Biomarker Predicts Response to CAR T-Cell Therapy in CLL
Only a subset of patients with advanced CLL achieve a complete and durable response to CAR T-cell therapy, and now researchers may have discovered the reason for that.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Genprex Announces $10 Million Private Placement
AUSTIN, Texas, May 7, 2018 -- (Healthcare Sales & Marketing Network) -- Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today th... Biopharmaceuticals, Oncology, Venture Capital Genprex, Oncoprex, immunogene therapy, NSCLC (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 7, 2018 Category: Pharmaceuticals Source Type: news

Lung cancer warning - this is why you should never ignore chest pain
CANCER symptoms vary depending on which part of the body is affected by a tumour. But, you should never ignore chest pain, as it could be a sign of deadly lung cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - May 7, 2018 Category: Consumer Health News Source Type: news

Poor Prognosis for Interval Breast Cancer After Negative Mammo
MONDAY, May 7, 2018 -- The likelihood of having breast cancer with a poor prognosis is increased for cancer diagnosed after a screening mammography with negative results, according to a research letter published online May 3 in JAMA Oncology. Anne... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2018 Category: Pharmaceuticals Source Type: news

Parenting Fears Harm Well-Being of Women With Metastatic Cancer
MONDAY, May 7, 2018 -- Among women with metastatic cancer and dependent children, parenting concerns negatively impact health-related quality of life (HRQOL), according to a study published online May 7 in Cancer. Eliza M. Park, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2018 Category: Pharmaceuticals Source Type: news

Meet Yvette Tremonti, a 2018 CFO of the Year honoree
Name:  Yvette Tremonti Title: Chief financial officer Company: Moffitt Cancer Center Years with company: 22 Category: Government and nonprofit We asked our CFO of the Year honorees a series of non-business questions, since all work and no play makes CFOs a dull group. What do you collect, if an ything? I don’t collect anything. Your first car: Toyota Celica Your walk-up music at The Trop: "The Climb" – Miley Cyrus Who plays you in the movie? Diane Lane Favorite restaurant in the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 7, 2018 Category: Pharmaceuticals Authors: Chris Erickson Source Type: news

Chemical octopus catches sneaky cancer clues, trace glycoproteins
Cancer drops sparse chemical hints of its presence early on, but unfortunately, many of them are in a class of biochemicals that could not be detected thoroughly, until now. Researchers at the Georgia Institute of Technology have engineered a chemical trap that exhaustively catches what are called glycoproteins, including minuscule traces that have previously escaped detection. (Source: World Pharma News)
Source: World Pharma News - May 7, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Groundbreaking workers' compensation case makes link between benzene and cancer
Mitch LaPrade had an 11-year battle to prove that his cancer is linked to contact with the chemical benzene at the printing company where he worked. But firefighters with the exact same form of leukemia are given automatic acknowledgement that benzene exposure on the job is to blame. (Source: CBC | Health)
Source: CBC | Health - May 7, 2018 Category: Consumer Health News Tags: News/Canada Source Type: news

Ask How Aggressive Is Melanoma Cancer
How Aggressive Is Melanoma Cancer? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 7, 2018 Category: General Medicine Source Type: news

Ask Is Melanoma Cancer Hereditary
Is Melanoma Cancer Hereditary? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 7, 2018 Category: General Medicine Source Type: news

Drug Duo Approved for Aggressive Thyroid Cancer
Title: Drug Duo Approved for Aggressive Thyroid CancerCategory: Health NewsCreated: 5/4/2018 12:00:00 AMLast Editorial Review: 5/7/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 7, 2018 Category: Cancer & Oncology Source Type: news

High Insurance Deductibles Lead Breast Cancer Patients to Delay Care: Study
Title: High Insurance Deductibles Lead Breast Cancer Patients to Delay Care: StudyCategory: Health NewsCreated: 5/4/2018 12:00:00 AMLast Editorial Review: 5/7/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 7, 2018 Category: Cancer & Oncology Source Type: news

Texas Oncology Receives 2018 PBMI Excellence Award for Care Management Strategies
DALLAS (May 7, 2018) — Texas Oncology, a practice in The US Oncology Network (The Network), received a 2018 Excellence Award from Pharmacy Benefit Management Institute® (PBMI) for its Medically Integrated Pharmacy Management (MIPM) approach to achieve better results in cancer care. The MIPM model in... (Source: McKesson News)
Source: McKesson News - May 7, 2018 Category: Information Technology Source Type: news

Novel PET tracer could help assess arthritis
Researchers from South Korea have developed a novel PET tracer that can be...Read more on AuntMinnie.comRelated Reading: PET imaging could help personalize cancer treatment PET tracer could better assess lung ailments PET tracks Zika virus, disease progression in mice Novel PET agent could sniff out neurological disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 7, 2018 Category: Radiology Source Type: news

ASBrS: Regular mammo screening = less-invasive treatment
Regular breast cancer screening, particularly in younger women, translates...Read more on AuntMinnie.comRelated Reading: ASBrS: No, we're not overtreating DCIS ASBrS: 50% of women under 45 at elevated breast cancer risk ASBrS: For node-positive breast cancer, radiotherapy is best ASBrS: Radiotherapy after mastectomy may not be beneficial ASBrS: RF ablation shows promise; thermography not so much (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 7, 2018 Category: Radiology Source Type: news

Medical News Today: Experimental drug targets prostate cancer's chief weakness
In prostate cancer, recurring tumors become aggressive and treatment-resistant. Why does this happen, and how can it be prevented? A new study weighs in. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 7, 2018 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Roche's Tecentriq combo wins fast FDA review in race to catch rivals
ZURICH (Reuters) - Roche's immunotherapy combination that includes Tecentriq, Avastin and chemotherapy will get an accelerated review by U.S. regulators for use as an initial treatment of a common form of lung cancer, the Swiss drugmaker said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - May 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche's Tecentriq combination to get speedy FDA review
ZURICH (Reuters) - Roche's immunotherapy combination that includes Tecentriq, Avastin and chemotherapy will get a speeded-up review by U.S. regulators for use in initial treatment of people with a common form of lung cancer, the Swiss drugmaker said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - May 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA grants priority review to Roche ’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab), in combination with Avastin® (bevacizumab), paclitaxel and carboplatin (chemotherapy), for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Media News)
Source: Roche Media News - May 7, 2018 Category: Pharmaceuticals Source Type: news

FDA grants priority review to Roche ’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab), in combination with Avastin® (bevacizumab), paclitaxel and carboplatin (chemotherapy), for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Investor Update)
Source: Roche Investor Update - May 7, 2018 Category: Pharmaceuticals Source Type: news

FDA grants priority review to Roche ’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab), in combination with Avastin® (bevacizumab), paclitaxel and carboplatin (chemotherapy), for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Media News)
Source: Roche Media News - May 7, 2018 Category: Pharmaceuticals Source Type: news

Vigorous exercise reduces tiredness in testicular cancer survivors
(Cancer Research UK) High-intensity interval training reduces tiredness and improves self-esteem for testicular cancer survivors, according to a study published in the British Journal of Cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news

By 2030, prostate and lung cancers expected to be most common cancers among HIV population
(American College of Physicians) Despite declines in cancer incidence rates among HIV-infected people, cancer will remain a significant concern as this patient population ages. By 2030, prostate and lung cancers are projected to be the most common cancers among individuals aging with HIV. The findings are published in Annals of Internal Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news

Generic options provide limited savings for expensive drugs
(Vanderbilt University Medical Center) Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released today in its May issue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news

Could reading our circadian clocks according to DNA repair optimize chemotherapy?
(University of North Carolina Health Care) For the first time, the lab of Nobel laureate Aziz Sancar measured DNA repair after cisplatin treatment throughout the entire genome of a mammal over the 24-hour circadian cycle. They found DNA repair of normal tissue was most robust predawn and pre-dusk in mice, and these could represent the best times for treatment using the anti-cancer drug cisplatin, though much more work needs to be done. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news

Chemical octopus catches sneaky cancer clues, trace glycoproteins
(Georgia Institute of Technology) Certain minuscule cancer signals easily evade detection, but perhaps no longer. Biomarkers made of glycoproteins are bound to get snared in the tentacles of this chemical octopus that Georgia Tech chemists devised over several years. The monstrous molecule could also be a windfall for the rising field of glycoscience. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news

Understanding how DNA is selectively tagged with 'do not use' marks
(Salk Institute) Salk scientists identify proteins that target specific DNA regions to keep genetic material under control. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news

A new connection between glucose and lipid regulation in cancer metabolism
(American Society for Biochemistry and Molecular Biology) Researchers at Albert Einstein College of Medicine and Shanghai Jiao Tong University School of Medicine in China have identified an enzyme that helps cancer cells make the building materials they need to quickly proliferate. Inhibiting this enzyme could be a strategy to slow down cancer growth, leading to more effective treatments. The study was published in the April 27 issue of the Journal of Biological Chemistry. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news

Study discovers new molecular mechanism likely involved in cancer metastasis
(University of Maryland Baltimore County) Scientists knew the PDK1 signaling pathway was active in metastasizing cancer cells, but no one knew why. New research has found for the first time that the PDK1 pathway regulates the formation of a three-protein core complex that facilitates purine biosynthesis. Further work aims to map all the protein complexes and signaling pathways they regulate in cancer cells, which would open doors to new ways of disrupting or even preventing metastasis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news

Leukemia protective role of Y chromosome gene discovered
(Wellcome Trust Sanger Institute) Scientists have discovered the first leukemia protective gene that is specific to the male-only Y chromosome. Researchers at the Wellcome Sanger Institute and the University of Cambridge found that this Y-chromosome gene protects against the development of acute myeloid leukemia (AML) and other cancers. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 7, 2018 Category: Biology Source Type: news

Preclinical M.D. Anderson study suggests ARID1a may be useful biomarker for immunotherapy
(University of Texas M. D. Anderson Cancer Center) Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas M.D. Anderson Cancer Center. The preclinical study suggests that mutations in ARID1a could be beneficial in predicting immunotherapy success. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 7, 2018 Category: Biology Source Type: news

Built for speed: DNA nanomachines take a (rapid) step forward
(Arizona State University) In a new study, researchers from ASU, University of Michigan, the Wyss Institute, the Dana Farber Cancer Institute and the Department of Biological Chemistry at Harvard describe an innovative DNA walker, capable of rapidly traversing a prepared track. Rather than slow, tentative steps across a surface, the DNA acrobat cartwheels head over heels, covering ground 10- to 100-fold faster than previous devices. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 7, 2018 Category: Biology Source Type: news

Pioneering new 3D cancer model to speed new treatments
(University of Virginia Health System) A new 3D cancer model that can mimic the complex nature and behavior of a real tumor will accelerate the development of new and better cancer treatments. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2018 Category: International Medicine & Public Health Source Type: news

A more affordable drug for neuroendocrine tumors diagnostics passing preclinical tests
(Tomsk Polytechnic University) Radiopharmaceuticals developed at Tomsk Polytechnic University will make the diagnostics of rare neuroendocrine tumors and prostate cancer more affordable thanks to the replacement of pricey radionuclides with reasonable technetium. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2018 Category: International Medicine & Public Health Source Type: news

C-Path receives COA qualification from FDA for the non-small cell lung cancer SAQ
(Critical Path Institute (C-Path)) Critical Path Institute's (C-Path) Patient-Reported Outcome (PRO) Consortium announces its second clinical outcome assessment (COA) qualification from the US Food and Drug Administration (FDA). The qualification of the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) for exploratory use represents another major milestone for the PRO Consortium and, specifically, for the NSCLC Working Group.   This is the culmination of a multi-year collaboration between FDA's Center for Drug Evaluation and Research (CDER) and the PRO Consortium. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2018 Category: International Medicine & Public Health Source Type: news

Breast cancer: Discovery of a protein linked to metastasis
(University of Montreal) Montreal researchers experimentally block the spread of a type of breast cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2018 Category: International Medicine & Public Health Source Type: news

Ophthalmologists link immunotherapy with a serious eye condition
(Michigan Medicine - University of Michigan) Eye inflammation and uveal effusion develop among patients taking anti-cancer immune checkpoint inhibitor therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2018 Category: International Medicine & Public Health Source Type: news

For mothers with advanced cancer, parenting concerns affect emotional well-being
(UNC Lineberger Comprehensive Cancer Center) A new study from the UNC Lineberger Comprehensive Cancer Center shows that parenting concerns have a significant impact on the mental and emotional health of women with advanced cancer. In particular, they found that a mother's emotional well-being was significantly linked with whether she had communicated with her children about her illness, and her concerns about how her illness will financially impact her children. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2018 Category: International Medicine & Public Health Source Type: news

Parenting concerns create challenges for mothers with advanced cancer and dependent children
(Wiley) A new study indicates that parenting concerns are associated with poor health-related quality of life among women with metastatic cancer who are parents of dependent children. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2018 Category: International Medicine & Public Health Source Type: news

Leading CAR-T Company Broadens Treatment Pipeline
TC BioPharm will collaborate with Scotia Biologics to develop proprietary CAR-T treatments for cancer and anti-viral indications. First CAR-T products will target solid tumours(PRWeb May 07, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15468263.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 7, 2018 Category: Pharmaceuticals Source Type: news

Women ’s Dermatologic Society to Offer Skin Cancer Screenings
Award Winning Play Safe in the Sun Program Announces 2018 Play Safe Season(PRWeb May 07, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15466046.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 7, 2018 Category: Pharmaceuticals Source Type: news

Tata Trusts to set up Cancer Care Hospital in Bhubaneswar
Apart from the apex hospital, the state government also entered into partnership with the Tata Trusts for a comprehensive cancer care programme under which the district level hospitals and medical colleges will be equipped to provide better cancer care. (Source: The Economic Times)
Source: The Economic Times - May 7, 2018 Category: Consumer Health News Source Type: news

Cancer: 'If exercise was a pill it would be prescribed to every patient'
Leading Australian researchers back world-first campaign for activity to be part of any treatment•Sign up to receive the top stories in Australia every day at noonExercise should be prescribed to all cancer patients, and not to do so would be harmful, some of Australia ’s leading experts on cancer have warned.The Clinical Oncology Society of Australia has launched its position statement on the role of exercise alongside surgery, chemotherapy or radiation in cancer care.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 6, 2018 Category: Science Authors: Guardian staff Tags: Cancer Health Medical research Australia news Source Type: news

Why tests can do more harm than good for some women, says DR ELLIE CANNON
On Wednesday, Health Secretary Jeremy Hunt admitted that 450,000 women aged 68 to 71 had not been invited to their final routine breast cancer scan. (Source: the Mail online | Health)
Source: the Mail online | Health - May 6, 2018 Category: Consumer Health News Source Type: news

Don't bother with catch-ups, says breast scan professor  
Women  who missed out on mammograms due to a computer error should ignore invitations for a ‘catch-up’ scan, according to an architect of the NHS breast cancer screening programme. (Source: the Mail online | Health)
Source: the Mail online | Health - May 6, 2018 Category: Consumer Health News Source Type: news

British women who have had boob jobs at risk of deadly cancer
Hundreds of British women who have had breast-enhancement surgery are at risk a deadly form of cancer triggered by their implants, say scientists. (Source: the Mail online | Health)
Source: the Mail online | Health - May 6, 2018 Category: Consumer Health News Source Type: news

Large-scale study proves that cell tower radiation causes cancer... where is the apology from the media for years of LYING about it?
(Natural News) The concept of cell tower radiation causing cancer used to be tinfoil hat territory – or at least that’s what those with vested interests in the technology wanted people to think. Now, however, the body of scientific evidence indicating that cell tower radiation can cause cancer is growing too big to ignore. The... (Source: NaturalNews.com)
Source: NaturalNews.com - May 6, 2018 Category: Consumer Health News Source Type: news

Niacin (vitamin B3) can prevent melanoma, scientists confirm
(Natural News) Although research is still in progress, there is currently no single drug or combination of drugs that can effectively treat the deadliest form of skin cancer known as melanoma. Fortunately, a recent study has shown that vitamin B3, or niacin, may play an important role in the prevention and progression of the disease.... (Source: NaturalNews.com)
Source: NaturalNews.com - May 6, 2018 Category: Consumer Health News Source Type: news

A lot of people believe indoor tanning is safe. The truth is, tanning beds injure thousands of people each year badly enough to go to a hospital, and that ’ s just the beginning -- the end may be skin #cancer @CDC_Cancer https://go.usa.gov/xnWd3   pic.twitter.com/BzbHRkem7a
A lot of people believe indoor tanning is safe. The truth is, tanning beds injure thousands of people each year badly enough to go to a hospital, and that’s just the beginning -- the end may be skin #cancer @CDC_Cancer https://go.usa.gov/xnWd3  pic.twitter.com/BzbHRkem7a (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - May 5, 2018 Category: Medical Devices Authors: ( at NCIprevention) Source Type: news